Blinded Celecoxib



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Osteoarthritis 26.1%
Rheumatoid Arthritis 20.7%
Adenocarcinoma Of Colon 16.3%
Non-small Cell Lung Cancer 10.9%
Hypertension 4.4%
Prophylaxis 3.2%
Type 2 Diabetes Mellitus 2.6%
Supplementation Therapy 1.9%
Breast Cancer 1.6%
Arthralgia 1.4%
Arthritis 1.4%
Bladder Transitional Cell Carcinoma 1.4%
Colon Cancer Stage Iii 1.4%
Dyslipidaemia 1.4%
Depression 1.2%
Back Pain 1.1%
Colon Cancer 1.1%
Anxiety 0.9%
Hypothyroidism 0.7%
Atrial Fibrillation 0.5%
Embolism 19.0%
Myocardial Infarction 9.5%
Urinary Tract Infection 9.5%
Renal Failure Acute 7.1%
Atrial Fibrillation 4.8%
Death 4.8%
Neutrophil Count Decreased 4.8%
Pulmonary Hypertension 4.8%
Pyrexia 4.8%
Sepsis 4.8%
White Blood Cell Count Decreased 4.8%
Blood Creatinine Increased 2.4%
Cardiac Arrest 2.4%
Cerebral Ischaemia 2.4%
Cerebrovascular Accident 2.4%
Cor Pulmonale 2.4%
Fatigue 2.4%
Gastritis 2.4%
Gastroenteritis 2.4%
Hyperglycaemia 2.4%
Secondary
Osteoarthritis 46.0%
Rheumatoid Arthritis 35.5%
Arthritis 3.4%
Prophylaxis 3.1%
Hypertension 2.5%
Supplementation Therapy 1.6%
Spinal Osteoarthritis 1.0%
Depression 0.7%
Diverticulitis 0.6%
Dyslipidaemia 0.6%
Pain 0.6%
Prophylaxis Against Gastrointestinal Ulcer 0.6%
Type 2 Diabetes Mellitus 0.6%
Diarrhoea 0.5%
Renal Failure Acute 0.5%
Erectile Dysfunction 0.5%
Gastrooesophageal Reflux Disease 0.5%
Colorectal Cancer Metastatic 0.4%
Diabetes Mellitus 0.4%
Hypothyroidism 0.4%
Atrial Fibrillation 8.5%
Coronary Artery Stenosis 8.5%
Vasculitis 8.5%
Oedema Peripheral 5.9%
Upper Gastrointestinal Haemorrhage 5.9%
Cholecystitis Acute 5.1%
Colitis 5.1%
Pulmonary Oedema 5.1%
Renal Impairment 5.1%
Thrombophlebitis 5.1%
Dyspnoea Exertional 4.2%
Knee Arthroplasty 4.2%
Myocardial Infarction 4.2%
Nephrotic Syndrome 4.2%
Arrhythmia 3.4%
Dyspnoea 3.4%
Haematoma 3.4%
Iron Deficiency Anaemia 3.4%
Osteoarthritis 3.4%
Renal Failure Acute 3.4%
Interacting
Arthritis 100.0%
Drug Interaction 50.0%
Red Blood Cell Count Decreased 50.0%